7575 Stock Overview
A medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. More details
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 1/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 5/6 |
Rewards
Risk Analysis
No risks detected for 7575 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Japan Lifeline Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | JP¥1,333.00 |
52 Week High | JP¥1,362.00 |
52 Week Low | JP¥970.00 |
Beta | 0.14 |
1 Month Change | 4.63% |
3 Month Change | 12.58% |
1 Year Change | 12.39% |
3 Year Change | 25.64% |
5 Year Change | -12.36% |
Change since IPO | 869.45% |
Recent News & Updates
Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥46.00
Dec 02Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report
Aug 04Recent updates
Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥46.00
Dec 02Analysts Have Made A Financial Statement On Japan Lifeline Co., Ltd.'s (TSE:7575) First-Quarter Report
Aug 04Japan Lifeline Co., Ltd. Just Missed EPS By 6.2%: Here's What Analysts Think Will Happen Next
May 06Japan Lifeline (TSE:7575) Is Increasing Its Dividend To ¥42.00
Mar 02Shareholder Returns
7575 | JP Medical Equipment | JP Market | |
---|---|---|---|
7D | -1.2% | -1.4% | -1.5% |
1Y | 12.4% | 14.7% | 13.7% |
Return vs Industry: 7575 underperformed the JP Medical Equipment industry which returned 14.7% over the past year.
Return vs Market: 7575 underperformed the JP Market which returned 13.7% over the past year.
Price Volatility
7575 volatility | |
---|---|
7575 Average Weekly Movement | 2.6% |
Medical Equipment Industry Average Movement | 3.6% |
Market Average Movement | 3.6% |
10% most volatile stocks in JP Market | 7.3% |
10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 7575 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 7575's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1981 | 1,216 | Keisuke Suzuki | www.japanlifeline.com |
Japan Lifeline Co., Ltd., a medical device company, develops, produces, imports, distributes, and trades in cardiovascular related medical devices in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablation catheters, endoscopic balloon ablation systems, esophageal temperature monitoring systems, internal atrial cardioversion systems, and radio-frequency transseptal needles. Its cardiovascular and endografting products consist of vascular and open stent grafts, and abdominal stent-grafts, as well as embolic coil deploying systems; and coronary and peripheral intervention products include PTCA and PTA guide wires, and PTCA balloon catheters.
Japan Lifeline Co., Ltd. Fundamentals Summary
7575 fundamental statistics | |
---|---|
Market cap | JP¥93.44b |
Earnings (TTM) | JP¥7.92b |
Revenue (TTM) | JP¥54.24b |
11.8x
P/E Ratio1.7x
P/S RatioIs 7575 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
7575 income statement (TTM) | |
---|---|
Revenue | JP¥54.24b |
Cost of Revenue | JP¥21.52b |
Gross Profit | JP¥32.72b |
Other Expenses | JP¥24.80b |
Earnings | JP¥7.92b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 112.94 |
Gross Margin | 60.32% |
Net Profit Margin | 14.60% |
Debt/Equity Ratio | 9.7% |
How did 7575 perform over the long term?
See historical performance and comparisonDividends
3.5%
Current Dividend Yield39%
Payout RatioDoes 7575 pay a reliable dividends?
See 7575 dividend history and benchmarksJapan Lifeline dividend dates | |
---|---|
Ex Dividend Date | Mar 28 2025 |
Dividend Pay Date | Jun 27 2025 |
Days until Ex dividend | 96 days |
Days until Dividend pay date | 187 days |
Does 7575 pay a reliable dividends?
See 7575 dividend history and benchmarksCompany Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/21 22:44 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Japan Lifeline Co., Ltd. is covered by 12 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Yang Luo | CLSA |
Steven Liu | CLSA |
null null | Company Forecast |